We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Capsulution NanoScience Starts New Feasibility Studies
News

Capsulution NanoScience Starts New Feasibility Studies

Capsulution NanoScience Starts New Feasibility Studies
News

Capsulution NanoScience Starts New Feasibility Studies

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Capsulution NanoScience Starts New Feasibility Studies"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Capsulution NanoScience AG has commenced two feasibility studies in the area of pharmaceutical formulation (drug delivery) that have been commissioned by two renowned industrial clients.

Using the proprietary LBL-Technology, both studies aim at increasing the bioavailability of several new chemical entities (NCEs) in the human body.

Particularly the transport of water insoluble compounds like a wide range of drug candidates in the development pipelines of pharmaceutical companies will be optimized during the studies.

“We are receiving a great deal of interest from drug manufacturers in our patented technology,” said Maria González Ferreiro, Director Business Development of Capsulution NanoScience AG.

“Both studies are aimed at close adaptations of our patented LBL-Technology® to the requirements of the pharmaceutical industry.”

Advertisement